Stoke Therapeutics, Inc. (STOK)
29.46
-0.58
(-1.95%)
USD |
NASDAQ |
Jan 23, 16:00
29.46
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics Research and Development Expense (TTM): 117.76M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.524B |
| Insmed, Inc. | 695.91M |
| Aldeyra Therapeutics, Inc. | 35.99M |
| Mirum Pharmaceuticals, Inc. | 178.77M |
| Moderna, Inc. | 3.271B |